Cytosorbents
CTSO
#10486
Rank
A$32.93 M
Marketcap
A$0.52
Share price
-21.30%
Change (1 day)
-70.96%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -A$20.21 Million

According to Cytosorbents's latest financial reports the company's current earnings are A$36.97 Million. In 2024 the company made an earning of -A$32.93 Million, an increase over its 2023 earnings that were of -A$42.49 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$20.21 Million-38.64%
2024 -A$32.93 Million-22.49%
2023 -A$42.49 Million-13.52%
2022 -A$49.13 Million34.04%
2021 -A$36.66 Million182.17%
2020 -A$12.99 Million-55.97%
2019 -A$29.5 Million14.17%
2018 -A$25.84 Million95.14%
2017 -A$13.25 Million-22.32%
2016 -A$17.05 Million39.1%
2015 -A$12.26 Million-12.89%
2014 -A$14.07 Million89%
2013 -A$7.45 Million26.65%
2012 -A$5.88 Million-26.02%
2011 -A$7.95 Million-288.45%
2010 A$4.21 M-4.17%
2009 A$4.39 M-287.19%
2008 -A$2.35 Million-47.12%
2007 -A$4.45 Million41.78%
2006 -A$3.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$5.42 B-29,618.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
A$1.12 B-6,233.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
A$80.42 M-537.85%๐Ÿ‡บ๐Ÿ‡ธ USA